Saturday, July 11, 2026

pharma · Type II Diabetes Mellitus

Hua Medicine

Hua Medicine is a pharma organization headquartered in CN. Primary therapeutic focus areas include Type II Diabetes Mellitus. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Clinical program

HMS5552

Phase 1 · small molecule · Type II Diabetes Mellitus

HMS5552 for Type II Diabetes Mellitus is a Phase 1 program (small_molecule) at Hua Medicine Limited with 1 ClinicalTrials.gov record(s).

← All Hua Medicine Limited projects Phase 1 small molecule completed

Internal code HMM0101

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hua Medicine Limited
Phase
Phase 1
Modality
small_molecule
Indication
Type II Diabetes Mellitus
Status
completed
Trials
1

Clinical trials